Hepatitis B virus (HBV) surface antigen (HBsAg) and antibody to HBsAg (antiHBs) are excellent markers for HBV infection and its immunity. A total of 414 patients, 312 Down syndrome and 102 non-Down's syndrome, were studied, and 142 were residents of an institution (RI), whereas 272 were in nonreside
Prevalence of hepatitis B virus markers in several institutions for the mentally handicapped in the autonomous community of Madrid
✍ Scribed by Diana Carrascosa; Ma De La Vega Ramírez; Angela Casado; Ma Roserio Je La Torre; Ma Encarnación Lópezfernández; Julia Sáez
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 440 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1042-0533
No coin nor oath required. For personal study only.
✦ Synopsis
In order to determine the prevalence of hepatitis B virus (HBV) markers, 400 patients were studied: 134 residents of an institution (RI) for the mentally retarded and 266 under non-residential care (NRC). In the residential institutions, all markers were absent in 69 (65.7%) of 105 patients with Down syndrome and 20 (69.0%) of 29 clients without Down syndrome. In the NRC clients, 167 (85.6%) of 195 patients with Down syndrome and 65 (91.5%) of 71 clients with other mental defects (psychologically and physically handicapped, autism) had negative tests for HBV markers. The prevalence of the hepatitis B surface antigen (HBsAg) was higher in institutionalized mentally retarded (RI) and older patients (21+ years). Examination of 195 Down patients revealed a higher frequency (1.4 times) of surface antigen carriers as strictly matched non-Down syndrome cases (point prevalences 14.2% and 10.3%, respectively). The higher prevalence in affected cases appears to be primarily associated with a longer persistence of antigenemia. Results related to the sex of the patients were less clear. Neither affected nor non-affected patients showed significant differences in prevalence among males and females. o 1995 Wiley-Liss, Inc.
📜 SIMILAR VOLUMES